The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 835 - 848
The Minimizing Adverse Haemorrhagic Events by Transradial Access Site and Systemic Implementation of Angiox (MATRIX) programme was designed to assess the...
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
2017 ESC | SITE | ANGIOGRAPHY | METAANALYSIS | MONOTHERAPY | PCI | ACUTE MYOCARDIAL-INFARCTION | INTERVENTION | ARTERY-DISEASE | MEDICINE, GENERAL & INTERNAL | Perioperative Care | Anticoagulants - administration & dosage | Humans | Middle Aged | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Acute Coronary Syndrome - complications | Radial Artery | Percutaneous Coronary Intervention - methods | Female | Femoral Artery | Myocardial Infarction - etiology | Mortality | Peptide Fragments - administration & dosage | Acute Coronary Syndrome - diagnostic imaging | Anticoagulants - adverse effects | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Coronary Angiography | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hemorrhage - chemically induced | Prosthesis Failure - etiology | Stents - adverse effects | Percutaneous Coronary Intervention - adverse effects | Anticoagulants (Medicine) | Coronary heart disease | Analysis | Cardiac patients | Intervention | Myocardial infarction | Short term | Surgical implants | Femur | Heart attacks | Angiography | Medical services | Clinical trials | Antithrombin | Matrix methods | Bleeding | Infusion | Elevation | Randomization | Motivation | Mathematical analysis | Calcium-binding protein | Implants | Cardiology | Thromboembolism | Stents | Cerebral infarction | Stroke | Medical imaging | Coronary artery | Glycoprotein | Glycoproteins | Angina pectoris | Patients | Thrombosis | Troponin | Inhibitors | Clopidogrel | Infarction | Heparin | Acute coronary syndromes | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2017, Volume 69, Issue 21, pp. 2592 - 2603
Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI). Objectives The...
coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | INTERVENTIONS | IMPACT | CARDIAC-CATHETERIZATION | CONTRAST-INDUCED NEPHROPATHY | VASCULAR ACCESS | INSIGHTS | Coronary heart disease | Analysis | Myocardial infarction | Heart | End-stage renal disease | Femur | Transfusion | Angioplasty | Hematocrit | Blood | Risk factors | Incidence | Elevation | Motivation | Surgery | Anticoagulants | Anemia | Regression analysis | Appendix | Inhibitors | Nephropathy | Embolization | Dialysis | Acute coronary syndromes | Health risk assessment | Circulation | Kidney transplantation | Intervention | Populations | Attitude control | Angiography | Prophylaxis | Clinical trials | Blood transfusion | Bleeding | Guidelines | Reduction | Risk assessment | Calcium-binding protein | Mathematical models | Lesions | Cardiology | Contrast media | Creatinine | Kidneys | Statistical analysis | Catheterization | Complications | Blood cells | Health risks | Management | Statistics | Cholesterol | Kidney diseases
coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | INTERVENTIONS | IMPACT | CARDIAC-CATHETERIZATION | CONTRAST-INDUCED NEPHROPATHY | VASCULAR ACCESS | INSIGHTS | Coronary heart disease | Analysis | Myocardial infarction | Heart | End-stage renal disease | Femur | Transfusion | Angioplasty | Hematocrit | Blood | Risk factors | Incidence | Elevation | Motivation | Surgery | Anticoagulants | Anemia | Regression analysis | Appendix | Inhibitors | Nephropathy | Embolization | Dialysis | Acute coronary syndromes | Health risk assessment | Circulation | Kidney transplantation | Intervention | Populations | Attitude control | Angiography | Prophylaxis | Clinical trials | Blood transfusion | Bleeding | Guidelines | Reduction | Risk assessment | Calcium-binding protein | Mathematical models | Lesions | Cardiology | Contrast media | Creatinine | Kidneys | Statistical analysis | Catheterization | Complications | Blood cells | Health risks | Management | Statistics | Cholesterol | Kidney diseases
Journal Article
European Heart Journal, ISSN 0195-668X, 04/2019, Volume 40, Issue 15, pp. 1226 - 1232
Aims In the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX) trial, adults with acute coronary...
Competing risk model | Percutaneous coronary intervention | Multistate model | Acute coronary syndrome | CARDIAC & CARDIOVASCULAR SYSTEMS | SCORE | COMPETING RISKS | FAILURE TIME DATA | PREDICTION | IMPACT | MULTISTATE MODELS | CARDIAC-CATHETERIZATION | INTERVENTION
Competing risk model | Percutaneous coronary intervention | Multistate model | Acute coronary syndrome | CARDIAC & CARDIOVASCULAR SYSTEMS | SCORE | COMPETING RISKS | FAILURE TIME DATA | PREDICTION | IMPACT | MULTISTATE MODELS | CARDIAC-CATHETERIZATION | INTERVENTION
Journal Article
European heart journal, ISSN 0195-668X, 01/2019, Volume 40, Issue 15, pp. 1226 - 1232
In the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX) trial, adults with acute coronary...
Journal Article
American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 6, pp. 838 - 845.e6
Background Transradial intervention (TRI) and bivalirudin infusion compared with transfemoral coronary intervention or unfractionated heparin plus glycoprotein...
Cardiovascular | BIVALIRUDIN | TRIAL | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PRIMARY PCI | INTERVENTION | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Female | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Radial Artery - surgery | Europe | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Postoperative Hemorrhage - etiology | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Survival Analysis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Femoral Artery - surgery | Percutaneous Coronary Intervention - adverse effects | Cardiac patients | Glycosaminoglycans | Intervention | Heart attacks | Medical imaging | Mortality | Cardiovascular disease | Clinical outcomes | Molecular weight | Studies | Pain | Ischemia | Coronary vessels | Electrocardiography | Acute coronary syndromes
Cardiovascular | BIVALIRUDIN | TRIAL | ANGIOGRAPHY | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | CLOPIDOGREL | ACUTE MYOCARDIAL-INFARCTION | ACUTE CORONARY SYNDROMES | ST-SEGMENT ELEVATION | PRIMARY PCI | INTERVENTION | Postoperative Hemorrhage - prevention & control | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Heparin - administration & dosage | Male | Antithrombins - administration & dosage | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - instrumentation | Percutaneous Coronary Intervention - methods | Platelet Aggregation Inhibitors - administration & dosage | Female | Myocardial Infarction - etiology | Platelet Aggregation Inhibitors - adverse effects | Radial Artery - surgery | Europe | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Postoperative Hemorrhage - etiology | Stroke - etiology | Antithrombins - adverse effects | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Survival Analysis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Femoral Artery - surgery | Percutaneous Coronary Intervention - adverse effects | Cardiac patients | Glycosaminoglycans | Intervention | Heart attacks | Medical imaging | Mortality | Cardiovascular disease | Clinical outcomes | Molecular weight | Studies | Pain | Ischemia | Coronary vessels | Electrocardiography | Acute coronary syndromes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 21, pp. 2592 - 2603
Abstract Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI)....
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.